Muller & Phipps (India) Limited

₹193.80As of Sun 8 Nov 2026, 12:00 UTC
BSE:501477Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 8.66%
Div yield —
ROE —
Drugs, Drug Proprietaries, and Druggists' Sundries
Beta (5Y) (0.45)
PE TTM —
TSR TTM (17.90%)
Mkt cap ₹121.1M
ROIC 1.67%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹211
8.72%
(60.92%)
Hold 11|2|7|12|3
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
4.26
4.27
4.67
5.22
17.91%
12.11%
17.79%
31.98%
Revenue₹M
6.189
6.351
6.168
6.295
14.62%
13.07%
7.98%
4.87%
Peers (US$1.290M)
Cap (US$)
PE
1.207M
4.730x
1.271M
—
Capital
TTM
5Y
10Y
Leveragex
0.343
(0.045)
(0.047)
EBIT/Intx
1.149
0.850
0.747
Own earn%
(64.13)
(108.83)
(111.39)
Sh yield%
27.68
57.88
54.74
Owners
Insiders/Inst%
2.34
40.86
Short interest%
4.54
SBC / revenue%
2.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
28–36
$1 testx
—
Incr. ROIC%
5